4 Healthcare Stock Stories to Keep Investors Well

Ampio Pharmaceuticals (NASDAQ:AMPE): Current price $3.94

Amplio announces the oral dosing of the first patient in a 505.b.2 clinical trial of the investigational drug Optina in diabetic macular edema. The trial will study Optina in adults suffering with recent onset diabetic macular edema. In 2012, the FDA awarded Optina 505.b.2 status and drugs designated under this pathway can be okayed on a single trial.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.